全文获取类型
收费全文 | 1466265篇 |
免费 | 99473篇 |
国内免费 | 3190篇 |
专业分类
耳鼻咽喉 | 22047篇 |
儿科学 | 45097篇 |
妇产科学 | 41819篇 |
基础医学 | 205327篇 |
口腔科学 | 43939篇 |
临床医学 | 122495篇 |
内科学 | 285535篇 |
皮肤病学 | 33981篇 |
神经病学 | 118582篇 |
特种医学 | 60312篇 |
外国民族医学 | 455篇 |
外科学 | 229483篇 |
综合类 | 31976篇 |
现状与发展 | 6篇 |
一般理论 | 467篇 |
预防医学 | 98350篇 |
眼科学 | 35206篇 |
药学 | 109034篇 |
4篇 | |
中国医学 | 3289篇 |
肿瘤学 | 81524篇 |
出版年
2018年 | 14286篇 |
2017年 | 11641篇 |
2016年 | 13452篇 |
2015年 | 15053篇 |
2014年 | 20057篇 |
2013年 | 30137篇 |
2012年 | 40089篇 |
2011年 | 41468篇 |
2010年 | 24701篇 |
2009年 | 23326篇 |
2008年 | 40003篇 |
2007年 | 43690篇 |
2006年 | 44265篇 |
2005年 | 43323篇 |
2004年 | 41979篇 |
2003年 | 40880篇 |
2002年 | 40266篇 |
2001年 | 67654篇 |
2000年 | 69221篇 |
1999年 | 58857篇 |
1998年 | 15844篇 |
1997年 | 14388篇 |
1996年 | 13687篇 |
1995年 | 12825篇 |
1994年 | 12032篇 |
1992年 | 44225篇 |
1991年 | 42616篇 |
1990年 | 41897篇 |
1989年 | 40764篇 |
1988年 | 38022篇 |
1987年 | 37484篇 |
1986年 | 35851篇 |
1985年 | 34009篇 |
1984年 | 25559篇 |
1983年 | 21627篇 |
1982年 | 13101篇 |
1981年 | 11971篇 |
1979年 | 24713篇 |
1978年 | 17650篇 |
1977年 | 15314篇 |
1976年 | 13827篇 |
1975年 | 15846篇 |
1974年 | 18710篇 |
1973年 | 18136篇 |
1972年 | 17419篇 |
1971年 | 16301篇 |
1970年 | 15455篇 |
1969年 | 14827篇 |
1968年 | 13953篇 |
1967年 | 12453篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
OLG München 《MedR Medizinrecht》2006,24(7):431-433
Abstrakt 1. Ein nicht ausgefülltes und nicht unterschriebenes Aufkl?rungsformular in der Krankenakte bildet ein Indiz nicht für, sondern
gegen die Durchführung eines Aufkl?rungsgespr?chs.
2. Wenn vor dem ?rztlichen Eingriff überhaupt keine Aufkl?rung erfolgt, genügt für den Beginn der Verj?hrung eines auf eine
Aufkl?rungspflichtverletzung gestützten Anspruchs die Kenntnis vom Eintritt schwerwiegender Komplikationen. Nicht erforderlich
ist das Wissen, dass sich ein typisches Risiko des Eingriffs verwirklicht hat. 相似文献
42.
Setting goals to maintain hope. 总被引:3,自引:0,他引:3
43.
44.
45.
Johannes Brettschneider Axel Petzold Sigurd D Süssmuth Georg B Landwehrmeyer Albert C Ludolph Jan Kassubek Hayrettin Tumani 《Movement disorders》2006,21(12):2224-2227
We aimed to evaluate the potential of the cerebrospinal fluid (CSF) axonal damage biomarker NfH(SMI35) in the laboratory-supported differential diagnosis of parkinsonian syndromes. Patients with idiopathic Parkinson's disease (PD; n = 22), multiple-system atrophy (MSA; n = 21), progressive supranuclear palsy (PSP; n = 21), corticobasal degeneration (CBD; n = 6), and age-matched controls (n = 45) were included. CSF levels of NfH(SMI35) were measured using ELISA. Levels of CSF NfH(SMI35) were elevated in PSP compared to PD and controls (P < 0.05 each). They were also significantly higher in MSA than in PD and controls (P < 0.05 each). NfH(SMI35) differentiated PD from PSP with a sensitivity of 76.5% and a specificity of 94.4%. Axonal damage as measured by CSF NfH(SMI35) is most prominent in the more rapidly progressive syndromes PSP and MSA as compared to PD or CBD. CSF NfH(SMI35) may therefore be of some value for the laboratory-supported differential diagnosis of atypical parkinsonian syndromes. 相似文献
46.
E Chankiewitz D Peschke L Herberg I Bazwinsky E Mühlbauer H-J Br?mme E Peschke 《Experimental and clinical endocrinology & diabetes》2006,114(5):262-269
The New Zealand obese mouse (NZO/Hl) is characterised by hereditary obesity and type-2 diabetes, including insulin resistance, hyperinsulinaemia, and glucose intolerance. In other diabetic models, it has been revealed that the proper functioning of the glucose transporter isoform 2 (GLUT2) is essential for adequate secretion of insulin. The aim of this study was to compare the distribution of islet cells and GLUT2, as well as the expression of GLUT2-mRNA, in the pancreas of NZO mice and metabolically unimpaired NMRI (Naval Medical Research Institute) mice. Pancreas tissue was obtained from different stages of development. For molecular determination of the expression level of GLUT2-mRNA, total-RNA was extracted from the pancreas and analysed by quantitative real-time RT-PCR. All investigated NZO mice displayed increased weight, elevated hyperinsulinaemia, and slightly enhanced blood glucose levels compared with the NMRI control mice. By means of immunofluorescence microscopy drastically reduced insulin levels were detected, which might be compensated by the observed islet cell hyperplasia and hypertrophy. Furthermore, the normally peripheral localisation of the alpha-cells within islets was disturbed. By contrast, there were no changes in somatostatin cell distribution. However, considerable differences appeared with regard to GLUT2: whereas the beta-cells of NMRI mice showed dense immunostaining of the GLUT2 transporter on the cell surface, in all age groups of NZO mice, GLUT2 on the plasma membranes was reduced and dispersed in the cytoplasm. These findings agree with the molecular biological results, which displayed decreased mRNA-expression of GLUT2. In summary, the observed alteration of islet morphology and of GLUT2 expression in diabetic mice complements our previous results from a superfusion protocol and further clarifies the mechanisms of diabetogenesis in NZO mice. 相似文献
47.
48.
49.
J S Lindholt S Juul H Fasting E W Henneberg 《European journal of vascular and endovascular surgery》2006,32(1):9-15
BACKGROUND: The aim of this study was to estimate the cost effectiveness of screening for abdominal aortic aneurysm (AAA). MATERIAL AND METHODS: All 12,639 men born in the years 1921-1933 (aged 64-73) living in Viborg County, Denmark, were randomly allocated either to receive an invitation to abdominal ultrasound scanning for AAA or to be controls. Costs for screening and surveillance were assessed prospectively. Diagnosis Related Group (DRG) costs from 1999 were used concerning admissions with uncomplicated and complicated operations. Admissions for AAA surgery were retrospectively classified according to complications in patient records. RESULTS: Mean follow-up time was 52 months. 76.6% of invited men attended screening, and 191 (4.0%) had an AAA. As previously reported, the cumulative 5-year AAA-specific mortality in the invited group was significantly reduced by 67% compared to the control group (P = 0.003). The costs were estimated to be Euro 11.23 per scan. The costs per life-year saved were Euro 9057 (Euro 5872-20,063) after 5 years, and were expected to decrease to Euro 2708 (Euro 1758-6031) after 10 years and to Euro 1825 (Euro 1185-4063) after 15 years. CONCLUSION: Screening of 64-73 years old males in Denmark seems cost effective. 相似文献
50.